Yüklüyor......
On the Regulatory Approval Pathway of Biosimilar Products
Biosimilars (or follow-on biologics) are a new class of medicine which enters the market subsequent to a previously approved version. They have demonstrated similarity to innovator biologic products in terms of quality, safety, and efficacy. The EMA has taken the lead in the regulatory approval fram...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3763644/ https://ncbi.nlm.nih.gov/pubmed/24281406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph5040353 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|